- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Managed Care Minute: May 9, 2015
A one-minute look at managed care news during the week of May 4, 2015, including global cancer drug spend, movements in telehealth, and changing behavior to reverse poor health.
This week IMS Health reported that total global cancer drug spending hit the $1 billion mark in 2014, up 10.3% from 5 years earlier. This growth was driven by earlier diagnosis, longer treatment duration, and increased effectiveness of cancer therapies.
Telehealth received a boost this week when UnitedHealth announced that through its coverage for doctor visits via telemedicine, 20 million Americans could access telemedicine and receive coverage for it by next year.
Thomas Morrow, MD, wrote in a contributed article to AJMC.com that behavior modifications are the keys to improving health outcomes. Dr Morrow is just one of AJMC.com's many contributors. You can see more here. If you are interested in becoming an AJMC.com contributor sign up here.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
